MiR-519d suppresses breast cancer tumorigenesis and metastasis via targeting MMP3

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Breast cancer (BC) remains a leading cause of mortality in women globally.
• MicroRNAs (miRNAs) are recognized as key regulators in cancer development, with many roles yet to be fully understood.
• Dysregulation of specific miRNAs is implicated in various cancers, including breast cancer.

Purpose of the Study:

• To investigate the role of miR-519d in breast cancer progression.
• To identify potential molecular targets of miR-519d in breast cancer.
• To explore the therapeutic potential of miR-519d in breast cancer treatment.

Main Methods:

• Quantitative real-time PCR (QRT-PCR) and Western blot to assess gene and protein expression.
• Cell Counting Kit-8 (CCK8) and 5-Ethynyl-2'-deoxyuridine (EdU) assays for cell proliferation analysis.
• Wound-healing and Transwell assays to evaluate cell migration and invasion capabilities.

Main Results:

• miR-519d expression was significantly reduced in human breast cancer tissues and MCF-7 cells.
• Overexpression of miR-519d suppressed proliferation, migration, and invasion of MCF-7 cells.
• Downregulation of miR-519d using an inhibitor promoted MCF-7 cell carcinogenesis.
• Matrix Metalloproteinase-3 (MMP3) was identified as a direct target of miR-519d.
• Correlative expression patterns between miR-519d and MMP3 were observed in BC tissues and cells.

Conclusions:

• The study uncovered a novel molecular interaction between miR-519d and MMP3 in breast cancer.
• miR-519d acts as a tumor suppressor by inhibiting proliferation, migration, and invasion.
• miR-519d represents a potential therapeutic strategy for breast cancer treatment.